Bayer Announces U.S. FDA Accepts New Drug Application and Grants Priority Review for Investigational…
Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted Priority Review for finerenone, an investigational drug for…
Read More...
Read More...
